Phenprobamate

CAS No. 673-31-4

Phenprobamate( —— )

Catalog No. M35839 CAS No. 673-31-4

Phenprobamate (MH 532) is a relaxant that acts on central skeletal muscle and has anticonvulsant and psychostimulant effects.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG 47 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Phenprobamate
  • Note
    Research use only, not for human use.
  • Brief Description
    Phenprobamate (MH 532) is a relaxant that acts on central skeletal muscle and has anticonvulsant and psychostimulant effects.
  • Description
    Phenprobamate (MH 532) is a relaxant that acts on central skeletal muscle and has anticonvulsant and psychostimulant effects.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    673-31-4
  • Formula Weight
    179.22
  • Molecular Formula
    C10H13NO2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(CCOC(N)=O)C1=CC=CC=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Chikusetsusaponin Ib

    Chikusetsusaponin-Ib is a triterpenoid saponin. It has a role as a metabolite.

  • 3-hydroxy-phthalican...

    3-Hydroxyphthalic anhydride is used to synthesize 3-hydroxyphthalic anhydride modified human serum albumin.

  • Neuropeptide W-30 (h...

    Neuropeptide W-30 (human) is an important stress mediator in the central nervous system that modulates the hypothalamus-pituitary-adrenal (HPA) axis and sympathetic outflow. Neuropeptide W-30 (human) is an endogenous ligand for the two structurally related orphan G-protein-coupled receptors (GPCRs) GPR7 and GPR8. Neuropeptide W-30 (human)activates and binds to both GPR7 and GPR8 at similar effective doses.